JP Stock MarketDetailed Quotes

4528 Ono Pharmaceutical

Watchlist
  • 1606.0
  • -2.0-0.12%
20min DelayMarket Closed Dec 20 15:30 JST
800.90BMarket Cap6.02P/E (Static)

Ono Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ono Pharmaceutical H1 FY2025 Earnings Date

Currency：JPYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
240.34B
--
-7.10%
EPS
--
29.53
--
-42.21%
Analyst Rating
Hold

Dec 9, 2024

Ono Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 126.497B--
Feb 3, 20252025/Q3-- / 128.924B--
Oct 31, 20242025/Q2122.664B / 116.450B--
Jul 31, 20242025/Q1117.675B / 112.414B--
May 9, 20242024/Q4112.769B / 123.574B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 126.497B--
Feb 3, 20252025/Q3-- / 128.924B--
Oct 31, 20242025/Q2122.664B / 116.450B--
Jul 31, 20242025/Q1117.675B / 112.414B--
May 9, 20242024/Q4112.769B / 123.574B--

Unlock Free Earnings Estimates

Ono Pharmaceutical Earnings Reports

  • Ono Pharmaceutical: Half-Year Report - Term 77 (2024/04/01 - 2025/03/31)

    Nov 5 19:00 ET

  • Ono Pharmaceutical: Confirmation letter

    Nov 5 19:00 ET

  • Ono Pharmaceutical: Revision of earnings forecasts and introduction of core-based performance

    Oct 30 23:00 ET

  • Ono Pharmaceutical: Interim Accounting Period Fiscal Period Ending March 2025 (April to September) Supplementary Financial Information (Consolidated IFRS)

    Oct 30 23:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 9, 2024

    Hold

    • Strong Buy

      15.39%

    • Buy

      0.00%

    • Hold

      38.46%

    • Underperform

      23.08%

    • Sell

      23.08%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Price
    % Chg

    No Data